TECH: who owns it, and who’s predicted to buy next
Bio-Techne Corp · Health Care · on the Prior Moves forward board for 2026-09-30 at rank #18. Research, not investment advice.
Predicted to buy next quarter
3 tracked investors are included in the model-ranked expectations for TECH in 2026-09-30. This is a forecast about a later filing, not a confirmation that anyone has bought the security or a recommendation to do so.
- Lee Ainslie · Maverick
- Chuck Akre · Akre Capital
- Brad Gerstner · Altimeter
Strongest ranked investor signal: Daniel Loeb. No calibrated purchase probability is shown.
Currently disclosed holders
No investor in our tracked set discloses TECH in their latest 13F. The prediction above is a forward call, not a mirror of current holdings.
Mutual fund and ETF holders
309 US mutual funds and ETFs from 150 fund families reported a position in TECH for the quarter ending 2026-06-30. Against their own report a quarter earlier, 84 raised shares, 20 opened a new position, 124 cut and 60 sold out. Source: SEC Form N-PORT, which funds file about 60 days after quarter end. Share counts, not trades: a change can reflect fund inflows rather than a decision about TECH.
| Fund family | Funds | Share of fund-held shares |
|---|---|---|
| Vanguard Index Funds | 4 | 29.6% |
| Fidelity Contrafund | 2 | 12.2% |
| Ishares Trust | 15 | 10.9% |
| Smallcap World Fund Inc | 1 | 7.2% |
| Eaton Vance Growth Trust | 1 | 5.2% |
| Trust For Professional Managers | 3 | 3.3% |
| Sequoia Fund Inc | 1 | 2.8% |
| First Trust Exchange-Traded Fund | 1 | 2.8% |
The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.
See the full ranked board on top picks, how the PriorScore is built on how it works, the honest edge numbers on methodology, and the running accuracy on the prediction leaderboard. Forward quarter 2026-09-30, data as of 2026-10-16. Research, not investment advice, see the disclaimer.